Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ohalo Genetics Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This specific matter is assigned to 1 distinct examiner and 1 distinct art unit. The 1 pending office action is the only active matter reported for this portfolio. Because the 1 distinct examiner and 1 distinct art unit are the only ones listed, the prosecution is concentrated in one administrative location.
STEPHENS, REBECCA JOHANNA is the busiest examiner for this portfolio, holding 1 busiest_examiner_pending action. This 1 pending office action is assigned to the only distinct examiner identified in the data. Practitioners can address the requirements of the Biotechnology & Pharmaceuticals area for this single case. The 1 distinct art unit involved provides the administrative context for the pending matter.
The 1 pending office action is handled by STEPHENS, REBECCA JOHANNA. This examiner is the only individual managing the company's current filings. The 1 distinct art unit and 1 distinct examiner indicate that the portfolio is not spread across different sections of the patent office. This structure allows for a direct response to the 1 pending office action within the Biotechnology & Pharmaceuticals area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEPHENS, REBECCA JOHANNA | 1 | 68.2% | +27.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19181163 | POLYPLOID HYBRID MAIZE BREEDING | STEPHENS, REBECCA JOHANNA | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19181163 | POLYPLOID HYBRID MAIZE BREEDING | STEPHENS, REBECCA JOHANNA | 1663 | §112DP | Non-Final OA | — | Pending | Apr 16, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOhalo Genetics Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Rebecca Johanna Stephens has the most, with 1 of Ohalo Genetics Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
